相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity
Jianwen Pei et al.
CANCER LETTERS (2019)
PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells
Perumal Elumalai et al.
LUNG CANCER (2019)
A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy
Jiwei Shen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib
Wenfeng Gou et al.
CANCER LETTERS (2018)
Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells
Daiying Zuo et al.
TOXICOLOGY IN VITRO (2017)
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer
Arjan Gower et al.
MOLECULAR ONCOLOGY (2016)
2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells
Jingwen Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway
Jian Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1
Claudia Voena et al.
ONCOTARGET (2016)
EML4-ALK induces epithelial-mesenchymal transition consistent with cancer stem cell properties in H1299 non-small cell lung cancer cells
Fuchun Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK
Diletta Fontana et al.
CANCER MEDICINE (2015)
Slug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression
Xiulan Zhao et al.
ONCOLOGY REPORTS (2015)
Anaplastic Lymphoma Kinase Gene Rearrangements in Cytological Samples of Non-Small Cell Lung Cancer
Agnese Proietti et al.
CANCER CYTOPATHOLOGY (2014)
ALK inhibitors in the treatment of advanced NSCLC
Cesare Gridelli et al.
CANCER TREATMENT REVIEWS (2014)
Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib
Ryohei Katayama et al.
CLINICAL CANCER RESEARCH (2014)
Next-Generation Sequencing Reveals a Novel NSCLC ALK F1174V Mutation and Confirms ALK G1202R Mutation Confers High-Level Resistance to Alectinib (CH5424802/RO5424802) in ALK-Rearranged NSCLC Patients Who Progressed on Crizotinib
Sai-Hong Ignatius Ou et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Identification of a Novel HIP1-ALK Fusion Variant in Non-Small-Cell Lung Cancer (NSCLC) and Discovery of ALK I1171 (I1171N/S) Mutations in Two ALK-Rearranged NSCLC Patients with Resistance to Alectinib
Sai-Hong Ignatius Ou et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib
Gouji Toyokawa et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer
Jason T. Fong et al.
PLOS ONE (2013)
Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition
Hua Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Ryohei Katayama et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers
Anton Wellstein
FRONTIERS IN ONCOLOGY (2012)
The EMT regulator slug and lung carcinogenesis
Jin-Yuan Shih et al.
CARCINOGENESIS (2011)
Hunting ALK to feed targeted cancer therapy
Anton Wellstein et al.
NATURE MEDICINE (2011)
Helicobacter pylori potentiates epithelial: mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7
Yinfei Yin et al.
GUT (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers
Catarina Castro Alves et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Herve Acloque et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development
Lidiya S. Orlichenko et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models
Roberta Vitali et al.
CLINICAL CANCER RESEARCH (2008)
Clues from worms: a Slug at Puma promotes the survival of blood progenitors
S. Haupt et al.
CELL DEATH AND DIFFERENTIATION (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma
WS Wu et al.
CELL (2005)
The Snail genes as inducers of cell movement and survival: implications in development and cancer
A Barrallo-Gimeno et al.
DEVELOPMENT (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis
YJ Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway
B Souttou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of the ALK tyrosine kinase gene in neuroblastoma
L Lamant et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
